Answers are grounded in this paper and cite their sources.
Gene therapy that targets the pancreas and intestines with delivery systems using nano-sized carriers such as viral and non-viral vectors could improve the control of blood glucose levels, resulting in an improved prognosis for patients with diabetes mellitus. Allogenic pancreatic islet cell transplantations using such delivery systems have been developed as therapeutic options for diabetes mellitus. This review focuses on transgenes and islet cell delivery systems using nano-sized carriers for the treatment of diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Ito et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: